GFUS
GDP-L-fucose synthase
Also known as: FCL_HUMAN, FX, P35B, SDR4E1, TSTA3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13630
- Gene
- GFUS
- Ensembl
- ENSG00000104522
- Chromosome
- 8
- Canonical length
- 321 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Tissue specific transplantation antigen P35B is a NADP(H)-binding protein. It catalyze the two-step epimerase and the reductase reactions in GDP-D-mannose metabolism, converting GDP-4-keto-6-D-deoxymannose to GDP-L-fucose. GDP-L-fucose is the substrate of several fucosyltransferases involved in the expression of many glycoconjugates, including blood group ABH antigens and developmental adhesion antigens. Mutations in this gene may cause leukocyte adhesion deficiency, type II. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
321 residues, UniProt reviewed canonical sequence.
>Q13630|GFUS
1 MGEPQGSMRI LVTGGSGLVG KAIQKVVADG AGLPGEDWVF VSSKDADLTD TAQTRALFEK
61 VQPTHVIHLA AMVGGLFRNI KYNLDFWRKN VHMNDNVLHS AFEVGARKVV SCLSTCIFPD
121 KTTYPIDETM IHNGPPHNSN FGYSYAKRMI DVQNRAYFQQ YGCTFTAVIP TNVFGPHDNF
181 NIEDGHVLPG LIHKVHLAKS SGSALTVWGT GNPRRQFIYS LDLAQLFIWV LREYNEVEPI
241 ILSVGEEDEV SIKEAAEAVV EAMDFHGEVT FDTTKSDGQF KKTASNSKLR TYLPDFRFTP
301 FKQAVKETCA WFTDNYEQAR KLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GFUS can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 109 nTPM
Expression across tissuesHPA
Tissue
- stomach: 109 nTPM
- pancreas: 94 nTPM
- esophagus: 86 nTPM
- liver: 83 nTPM
- skin: 79 nTPM
- salivary gland: 70 nTPM
Single-cell type
- late spermatids: 241 nCPM
- breast lactating cells: 184 nCPM
- gastric chief cells: 131 nCPM
- late primary spermatocytes: 70 nCPM
- suprabasal keratinocytes: 64 nCPM
- foveolar cells: 60 nCPM
Immune cell
- NK-cell: 64 nTPM
- T-reg: 58 nTPM
- plasmacytoid DC: 55 nTPM
- memory CD8 T-cell: 47 nTPM
- total PBMC: 46 nTPM
- memory CD4 T-cell: 43 nTPM
Brain region
- medulla oblongata: 19 nTPM
- cerebral cortex: 18 nTPM
- pons: 17 nTPM
- white matter: 17 nTPM
- midbrain: 15 nTPM
- choroid plexus: 15 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GFUS.
Disease | ImmuneIEDB
Conditions an epitope on GFUS was assayed in.
- multiple sclerosis T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.13
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 11% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 'de novo' GDP-L-fucose biosynthetic process
- GDP-mannose metabolic process
- leukocyte cell-cell adhesion
- positive regulation of endothelial cell migration
- positive regulation of endothelial cell-matrix adhesion via fibronectin
- T cell mediated cytotoxicity
Molecular functions
- electron transfer activity
- identical protein binding
- GDP-4-dehydro-D-rhamnose reductase activity
- GDP-L-fucose synthase activity
- GDP-mannose 3,5-epimerase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- NAD-dependent epimerase/dehydratase
- NAD(P)-binding domain superfamily
- NAD dependent epimerase/dehydratase family
- GDP-L-fucose synthase/GDP-L-colitose synthase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GFUS as an antibody target. Whether an autoantibody or antibody against GFUS could matter depends on whether native GFUS is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GFUS is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GFUS as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...